Discussion
CSL is investigating two potential new treatments for sickle cell disease: An injected monoclonal antibody designed to prevent pain crises by reducing the neutrophil levels in the blood: Researchers are studying whether the monoclonal antibody treatment can decrease the number of pain crises and reduce the chances of long-term injury…